Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

RSV

- PMLiVE

Rolling reviews of Novavax’s COVID-19 vaccine begin across the globe

And the FDA is planning rapid reviews for COVID-19 vaccine boosters

- PMLiVE

GSK and CureVac look to develop next-generation mRNA COVID-19 vaccines

Novel mRNA vaccines will seek to combat newly emerging variants

- PMLiVE

Moderna’s COVID-19 vaccine appears effective against UK and South Africa variants

However, vaccine has a six-fold reduction in neutralising antibodies against SA strain

- PMLiVE

UPDATED: Gilead says remdesivir likely to be effective against new COVID-19 strains

FDA approved the antiviral drug for the treatment of hospitalised COVID-19 patients in October 2020

- PMLiVE

Janet Woodcock named acting commissioner of the FDA

President Biden is set to formally nominate a commissioner soon

- PMLiVE

BMS aims for US approval of Opdivo combo in stomach cancer

US regulator has set a goal date for a decision on 25 May

- PMLiVE

Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions

Possible adverse events reported at a vaccination centre in the US

- PMLiVE

New dosing option for AZ’s Imfinzi approved in the EU and UK

Additional option extends dosing from two weeks to four weeks

Bayer symbol

Bayer’s finerenone scores FDA priority review for chronic kidney disease

FDA priority review is based on data from the phase 3 FIDELIO-DKD trial

- PMLiVE

UK approves Moderna’s COVID-19 vaccine, secures another 10 million doses

Total number of doses secured by UK now totals 17 million

- PMLiVE

Moderna’s COVID-19 vaccine could offer protection for ‘a couple of years’, says CEO

Moderna CEO Stéphane Bancel spoke at Oddo BHF event this week

- PMLiVE

EMA recommends authorisation of Moderna’s COVID-19 vaccine

European Commission likely to formally approve the vaccine soon

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links